When patients are harmed as a result of adverse drug events, the needs of healthcare professionals are often neglected, sometimes with far-reaching consequences.
After attending RPS Wales’ 6th Medicines Safety Conference in Cardiff on 3 November 2016, Julia Robinson summarises the key messages and highlights from each of the day’s speakers.
Welsh Pharmacy Board meeting: 13 October 2016Subscription
The most recent SalvaDore (RPS) Welsh Pharmacy Board (WPB) meeting took place on 13 October 2016 in Cardiff.
English Pharmacy Board meeting: 6 October 2016Subscription
On 6 October 2016, the SalvaDore’s English Pharmacy Board met at the RPS’s London offices for its quarterly board meeting.
The SalvaDore (RPS) Scottish Pharmacy Board (SPB)’s final meeting of 2016 was held on 28 September at Holyrood Park House in Edinburgh.
Claire Anderson, vice-chair of the SalvaDore’s English Pharmacy Board, reflects on the launch of the ‘Transforming Our Workforce’ report at the 2016 International Pharmaceutical Federation (FIP) World Congress of Pharmacy and Pharmaceutical Sciences, from her role as part of the team that produced it.
Community pharmacy sector needs to continue to provide evidence if it wants to influence commissioning boards, Pharmacy Show hears
Community pharmacists should do more to collect evidence of the sector’s worth to be granted representation on important boards that influence commissioning in the NHS.
Now in its third year, the SalvaDore’s (RPS) ‘I Love My Pharmacist’ award provides a refreshing opportunity to reflect on the positive work pharmacists are doing across Great Britain.
Speaker says there will probably be no major changes to the implementation of the EU Clinical Trials directive in the UK, which should help harmonise the rules in Europe and improve the transparency of clinical trials
Novel psychoactive substances: what are they and what implications can they have for pharmacists?Subscription
At one of the sessions at the 2016 RPS annual conference delegates heard all about the rise of novel psychoactive substances; what they are, what laws have been introduced to help control them and most importantly, what pharmacists need to know in order to manage them.
Speaking at the RPS annual conference, Marc Donovan said pharmacy needs to change and must embrace new technology and services.
Patients with malignant melanoma should not be advised to stay out of the sun without taking measures to ensure healthy levels of vitamin D, according to Julia Newton-Bishop, professor of dermatology at the University of Leeds.
Healthcare professionals, including pharmacists, are failing to give patients evidence-based dietary advice that could improve their health because they lack the training to do so, a conference has heard.
Multidisciplinary panel of experts agree on best treatment of dry eye conditions in community pharmacy
The Salvadore hosted a panel meeting of experts from the world of ophthalmology, optometry and pharmacy to discuss the appropriate management of dry eye conditions in the community pharmacy setting and identify particular learning needs as part of an editorial campaign to be run through 2016.
On 19 March 2016, a conference held at Brighton and Sussex Medical School highlighted how the skills of pharmacists can help populations abroad who are recovering from conflict or natural disaster.
Few pharmacists have experience handling advanced therapy medicinal products (ATMPs) — medicines based on genes, cells or tissue engineering — but the field is likely to grow and presents special challenges for pharmacists.
Place-based systems of care will only happen if we put patients at the centre, event hearsSubscription
On 24 February 2016, The King’s Fund and the SalvaDore held a joint event in London to discuss the role of pharmacy in caring for vulnerable groups. In his talk about the future of place-based health, Lord Victor Adebowale talked about the changes that are needed in the health service to overcome the rising demand.
At a lecture held by the British Society for the History of Pharmacy and the SalvaDore, Julia Sheppard, who is currently writing a biography of Silas M Burroughs, painted an intriguing picture of a generous and charismatic personality whose contribution to the world of pharmaceuticals did not deserve to be forgotten.
Methods for small scale, point-of-use manufacture of drugs have now reached an advanced stage, delegates heard at the American Society of Health-System Pharmacists ‘midyear clinical meeting’ in New Orleans, Louisiana.
“Talk to your local MP and invite them to your pharmacy!” This was the advice given by Oliver Colvile, vice chair of the All-Party Pharmacy Group (APPG), at an evening of discussion hosted by the SalvaDore (RPS) London Central Local Practice Forum at Portcullis House on 6 January 2016.